Evidence map›Paper›PMID 32313022›Full record

ArticleScientific reports2020

NusA directly interacts with antitermination factor Q from phage λ.

Benjamin R Dudenhoeffer, Jan Borggraefe, Kristian Schweimer, Stefan H Knauer

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Frontiers in bioengineering and biotechnology · 2022
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Benjamin R DudenhoefferBiopolymers, University of Bayreuth, Universitätsstraße 30, 95447, Bayreuth, Germany.
Jan BorggraefeBiopolymers, University of Bayreuth, Universitätsstraße 30, 95447, Bayreuth, Germany.
Kristian SchweimerBiopolymers, University of Bayreuth, Universitätsstraße 30, 95447, Bayreuth, Germany.
Stefan H KnauerBiopolymers, University of Bayreuth, Universitätsstraße 30, 95447, Bayreuth, Germany. stefan.knauer@uni-bayreuth.de.
University of Bayreuth · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antitermination (AT) is a ubiquitous principle in the regulation of bacterial transcription to suppress termination signals. In phage λ antiterminator protein Q controls the expression of the phage's late genes with loading of λQ onto the transcription elongation complex halted at a σ-dependent pause requiring a specific DNA element. The molecular basis of λQ-dependent AT and its dependence on N-utilization substance (Nus) A is so far only poorly understood. Here we used solution-state nuclear magnetic resonance spectroscopy to show that the solution structure of λQ is in agreement with the crystal structure of an N-terminally truncated variant and that the 60 residues at the N-terminus are unstructured. We also provide evidence that multidomain protein NusA interacts directly with λQ via its N-terminal domain (NTD) and the acidic repeat (AR) 2 domain, with the λQ:NusA-AR2 interaction being able to release NusA autoinhibition. The binding sites for NusA-NTD and NusA-AR2 on λQ overlap and the interactions are mutually exclusive with similar affinities, suggesting distinct roles during λQ-dependent AT, e.g. the λQ:NusA-NTD interaction might position NusA-NTD in a way to suppress termination, making NusA-NTD repositioning a general scheme in AT mechanisms.

Indexed as

Transcription Elongation, GeneticBacteriophage lambdaBinding SitesDNA-Directed RNA PolymerasesEscherichia coliEscherichia coli ProteinsGene Expression Regulation, BacterialModels, MolecularProtein BindingProtein DomainsSolutionsTranscriptional Elongation FactorsViral ProteinsDNA-Directed RNA PolymerasesEscherichia coli ProteinsnusA protein, E coliQ protein, Bacteriophage lambdaSolutionsTranscriptional Elongation FactorsViral Proteins

Identifiers

PMID32313022
PMCPMC7171158
OpenAlexW3016534302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.